Population: Adults

Individuals aged 18-64 years

Leppert

Italy Spain Switzerland
|
2022-2024
  • Adults
  • General population
  • Elderly
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Monoclonal antibodies
  • Temelimab

Liebich

Germany
|
2021
  • Adults
  • General population
  • Hospital wide
  • SARS-CoV-2
  • Post-COVID-19

Liira

Finland
|
2021-2023
  • Adults
  • General population
  • Outpatient clinic
  • Primary care
  • SARS-CoV-2
  • Post-COVID-19

Lindsay

United Kingdom
|
2021
  • Adults
  • Fragile population
  • SARS-CoV-2
  • Post-COVID-19

LoCoDiRe-Dys

Greece
|
2023-2024
  • Adults
  • General population
  • Elderly
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation

Löffelhardt

Germany
|
2020
  • Adults
  • General population
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19

ESOA-19

Portugal
|
2022
  • Adults
  • General population
  • Elderly
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Antivirals
  • Nirmatrelvir/Ritonavir
  • Molnupiravir

Evans

United Kingdom
|
2021-2022
  • Adults
  • Elderly
  • Fragile population
  • Outpatient clinic
  • Community
  • Non-hospital health centre
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Antivirals
  • Nirmatrelvir/Ritonavir
  • Monoclonal antibodies
  • Sotrovimab
  • Molnupiravir

EXER-COVID

Spain
|
2021-2022
  • Adults
  • General population
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation

EXPLAIN

United Kingdom
|
2022
  • Adults
  • General population
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19

Fellerhoff

Germany
|
2023
  • Adults
  • General population
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation
  • Fimo Health App

FemiAjao

United Kingdom
|
2020
  • Adults
  • General population
  • Elderly
  • SARS-CoV-2
  • Post-COVID-19